文献速递结核与非结核分枝杆菌

舌拭子与痰标本分子检测在四国结核病诊断中的检出率比较

Diagnostic Yield of Tongue Swab- Compared to Sputum-Based Molecular Testing for Tuberculosis in Four High-Burden Countries.
PubMed 文献 · Clin Infect Dis · 2026-01-01

这项横断面研究在菲律宾、越南、乌干达和赞比亚连续筛查疑似结核病患者,所有参与者提供舌拭子(MiniDock MTB检测),仅84.7%能提供痰标本。舌拭子分子检测检出率为3.8%,痰标本为4.1%,差异0.3%(95%CI -0.6至+1.2)在预设的非劣效界值内,支持舌拭子作为痰采集困难时的替代方案。

要点

  • 在四个高负担国家中,舌拭子分子检测的结核检出率非劣效于痰标本分子检测。
  • 结果在年龄、性别和HIV状态等关键亚组中一致。

核心结论

  • 舌拭子MiniDock MTB分子检测与痰标本分子检测相比,诊断产出非劣效(差异0.3%,95%CI -0.6至+1.2,在预设3.0%界值内)。
  • 支持在痰采集困难或涂片镜检仍为主要诊断方法的地区推广舌拭子平台。

研究设计与样本

  • 横断面研究(2024年7月至2025年1月),在菲律宾、越南、乌干达和赞比亚的卫生中心连续筛查疑似结核病患者,共纳入1639人。
  • 参与者提供舌拭子并在研究实验室使用MiniDock MTB检测;痰标本按国家指南采用WHO推荐的分子检测。
  • 诊断产出定义为所有参与者中阳性结果的比例,预设非劣效界值为3.0%。

主要发现

  • 1639名参与者中,851名(51.9%)为女性,415名(25.3%)诊断为HIV感染,132名(8.1%)为5岁以下儿童。
  • 所有参与者均提供舌拭子,仅1389名(84.7%)产生痰标本。
  • 舌拭子分子检测诊断产出为3.8%(63/1639),痰标本为4.1%(68/1639)。
  • 差异为0.3%(95%CI -0.6至+1.2),在预设非劣效界值内,且结果在国家及关键亚组(年龄、性别、HIV状态)中一致。

关键数值与推荐

  • 非劣效界值预设为3.0%。
  • 舌拭子检测使用MiniDock MTB Test(广州Pluslife Biotech Co., Ltd., 中国)。

临床怎么用

  • 舌拭子可作为痰标本采集困难或涂片镜检为主要诊断方法地区的替代标本类型。
  • 舌拭子平台可扩大样本获取,提高结核诊断覆盖。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tongue swabs are a promising alternative specimen for tuberculosis (TB) diagnosis. Although test specificity exceeds 98%, sensitivity is lower than sputum-based molecular testing. We investigated whether the use of tongue swabs could increase sample availability, resulting in similar diagnostic yield. METHODS: In this cross-sectional study (July 2024-January 2025), we screened consecutive people with presumptive TB at health centers in the Philippines, Vietnam, Uganda, and Zambia. Participants were asked to provide tongue swabs and referred for routine sputum collection. Tongue swabs were tested in research laboratories using the MiniDock MTB Test (Guangzhou Pluslife Biotech Co., Ltd., China); sputum was tested using WHO-recommended molecular testing per national guidelines. We compared diagnostic yield, defined as proportion of positive test results among all participants, between tongue swab- and sputum-based molecular testing with a prespecified 3.0% non-inferiority margin. RESULTS: Of 1639 participants, 851 (51.9%) were female, 415 (25.3%) were diagnosed with HIV, and 132 (8.1%) were children <5 years. All provided tongue swabs, but only 1389 (84.7%) produced sputum. Diagnostic yield was 3.8% (63/1639) for tongue swabs and 4.1% (68/1639) for sputum-based (68/1639, 4.1%) molecular testing. The difference (0.3%, 95% CI -0.6 to +1.2) was within the prespecified non-inferiority margin. Results were consistent across countries and key subgroups (age, sex, and HIV status). CONCLUSIONS: Tongue swab-based molecular testing with MiniDock MTB achieved non-inferior diagnostic yield compared with sputum-based molecular testing. These findings support scale-up of swab-based platforms as a cost-efficient alternative, particularly where sputum collection is challenging or smear microscopy remains the primary diagnostic method.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Moe CA, Luswata RK, Barrameda AJ, et al. Diagnostic Yield of Tongue Swab- Compared to Sputum-Based Molecular Testing for Tuberculosis in Four High-Burden Countries. Clin Infect Dis. 2026. PMID: 41804811. doi:10.1093/cid/ciag077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。